Little Green Pharma (LGP) Stock Price, News & Analysis

Company Overview

Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. It offers dried cannabis flower medicines, cannabis oils, tinctures, capsules, and APIs. The company was incorporated in 2016 and is based in West Perth, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: A$39.37 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LGP Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Little Green Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Little Green Pharma investors own include CIMIC Group (CIM), Aurizon (AZJ), Magellan Financial Group (MFG), CSL (CSL), Pendal Group (PDL), Platinum Investment Management (PTM) and Regis Resources (RRL).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:LGP
• CIK: N/A
• Web: www.littlegreenpharma.com
• Phone: 61 8 6280 0050
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$8.15 million
• Net Margins: -47.04%
• Pretax Margin: N/A
• Return on Equity: -11.67%
• Return on Assets: -5.20%

Debt

• Debt-to-Equity Ratio: 14.43
• Current Ratio: 2.82
• Quick Ratio: 1.60

Sales & Book Value

• Annual Sales: A$25.63 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.33 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 301,760,000
• Free Float: N/A
• Market Cap: A$39.37 million
• Optionable: Not Optionable
• Beta: 1.27